Anti-Human Deoxycytidine Kinase (dCK) Monoclonal Antibody

Tech ID: 22470 / UC Case 2012-031-0


dCK is an enzyme required for the phosphorylation of various deoxyribonucleosides and their nucleoside analogs. Deficiency of dCK has been shown to be associated with resistance to anticancer chemotherapeutic drugs (e.g. gemcitabine). dCK also has a known importance in the development of adaptive immune responses.


    The anti-human dCK monoclonal antibody allows physicians and researchers to study and detect dCK in patient samples. The mAb can be used for western blotting, immunoprecipitation, and immunohistochemistry of primary human tissue


Learn About UC TechAlerts - Save Searches and receive new technology matches


  • Witte, Owen N.

Other Information


antibody, monoclonal antibody, dCK, human deoxycytidine kinase, immunohistochemistry, immunology, chemotherapy, anti-metabolites, gemcitabine, cancer, pancreatic cancer, breast cancer, ovarian cancer, lung cancer

Categorized As